RemeGen Co. Ltd. (REGMF)
PNK: REGMF
· Real-Time Price · USD
5.06
0.00 (0.00%)
At close: Apr 25, 2025, 3:53 PM
0.00% (1D)
| Bid | 4.41 |
| Market Cap | 3.49B |
| Revenue (ttm) | 1.19B |
| Net Income (ttm) | -1.2B |
| EPS (ttm) | -0.37 |
| PE Ratio (ttm) | -13.68 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 5.41 |
| Volume | 400 |
| Avg. Volume (20D) | 6 |
| Open | 5.10 |
| Previous Close | 5.06 |
| Day's Range | 5.06 - 5.10 |
| 52-Week Range | 1.50 - 5.10 |
| Beta | 0.37 |
About REGMF
RemeGen Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States. The company offers Telitacicept (RC18) for use in the treatment of systemic lupus erythematosus an autoimmune disease and Disitamab Vedotin (RC48) for use in the treatment of various cancers. Its...
Industry Biotechnology
Sector Healthcare
IPO Date Jan 21, 2021
Employees 2,999
Stock Exchange PNK
Ticker Symbol REGMF
Website https://www.remegen.com